Flagship Pioneering is a venture capital firm that seeks to invest in the health technologies and life science sectors. The firm was founded in 2000 and is based in Cambridge, Massachusetts.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Tessera (Biotechnology) | 12-Jan-2021 | Later Stage VC | 00000 | Biotechnology | Generating Revenue | |
00000000 000000000 | 10-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Product Development | 000000 000000 00.0 |
0000000 (000000000 | 07-Jul-2020 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 000000 000000 00.0 |
000000 00000000000 | 22-Jun-2020 | 00000 00000 | 00000 | Other Agriculture | Generating Revenue | 00000000 000 00000000 00.0 |
0000 0000000000000 | 11-Jun-2020 | 00000 00000 | 00000 | Drug Discovery | Generating Revenue/Not Profitable | 0000000 0000 00 |
0000 000000000000 | 10-Dec-2019 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 000000 000000 00.0 |
000000 (0000 00000 | 08-Oct-2019 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 0000000 0000000000 00 |
0000000 0000000000 | 30-Aug-2019 | 00000 00000 | 000.00 | Drug Delivery | Generating Revenue/Not Profitable | 0000000 0000 00 |
Inari | 29-Jul-2019 | Later Stage VC | 0000 | Other Agriculture | Generating Revenue | 00000 00000 00.0 |
Valo Health | 05-Jul-2019 | Early Stage VC | 00000 | Drug Discovery | Startup | 00000 0000000 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Sigilon Therapeutics | 04-Dec-2020 | IPO | 00000 |
0000000 0000000000 | 23-Oct-2020 | 000 | 00000 |
000000 | 14-Oct-2020 | 000 | 000.00 |
0000000 0000000000 | 20-May-2020 | 000000 0000000000 | 00.000 |
0000000 | 14-May-2020 | 000000 0000000000 | 000.00 |
000000 00000000000 | 28-Jan-2020 | 000000000 00000000 | 00000 |
00000 0000000000 ( | 20-Dec-2019 | 000000000000000000 | |
0000000000 | 01-Sep-2019 | 000000000000000000 | |
Axcella | 09-May-2019 | IPO | 000.00 |
TransMedics | 02-May-2019 | IPO | 0000 |
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
This information is available in the PitchBook Platform. To explore Flagship Pioneering‘s full profile, request access.
Request a free trialInvestments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Noubar Afeyan Ph.D | Co-Founder & Chief Executive Officer | 00 | 0 | 00 | Cambridge, MA |
Chuck Carelli | Chief Financial Officer | Cambridge, MA | |||
Jeffery Moore | Chief Financial Officer, Flagship Labs | Cambridge, MA | |||
Robert Rosiello | Executive Partner & Chief Operating Officer | 0 | Cambridge, MA | ||
Edwin Kania Jr. | Co-Founder & Managing Partner | 00 | 0 | 0 | Cambridge, MA |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
ARCH Venture Partners | 6 | 0 |
![]() |
![]() |
|
Alexandria Venture Investments | 0 | 0 | 0 |
![]() |
![]() |
Alaska Permanent Fund | 0 | 0 |
![]() |
![]() |
|
Baillie Gifford | 0 | 0 |
![]() |
![]() |
|
Polaris Partners | 0 | 0 | 0 |
![]() |
![]() |